Background: non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP), which is considered as low-risk cancer, should be distinguished from the malignant invasive encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC). Improved discrimination of NIFTPs from invasive EFVPTCs using a molecular biomarker test could provide useful insights into pre- and post-surgical management of the indeterminate thyroid nodule. Galectin-3 (Gal-3), a β-galactosyl-binding molecule in the lectin group, is involved in different biological functions in well differentiated thyroid carcinomas. The aim of this study was to determine whether Gal-3 expression as a diagnostic marker could distinguish indolent NIFTP from inv...
OBJECTIVE: To analyze the utility of galectin-3 (Gal3) immunohistochemistry (IHC) on preoperatively...
Abstract: Background. Thyroid nodules are the most com-mon surgical disease of the thyroid. Fine-nee...
The distinction between benign and malignant thyroid tumors is critical for the management of patien...
Thyroid cancer is not very common, accounting for 1-2% of all cancers, with a population incidence o...
Introduction: Most of differentiated thyroid carcinomas should be easily revealed by fine-needle as...
Background: Galectin-3 is an endogenous beta-galactoside binding lectin implicated in neoplastic tra...
BACKGROUND: In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed in 2007, ...
The histologic diagnosis of the follicular variant of papillary thyroid carcinoma (FVPTC) may be tro...
Abstract: Background. Galectin-3 has been recently recog-nized as a promising presurgical marker of ...
BACKGROUND: In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed in 2007,...
Thyroid cancer is not very common, accounting for 1-2% of all cancers, with a population incidence o...
Ten to fifteen percent of fine-needle aspiration biopsy (FNAB) of thyroid nodules are indeterminate....
Abstract: Background. The determination of malignancy in follicular patterned thyroid lesions is bas...
OBJECTIVE AND DESIGN: Galectin-3 is a beta-galactoside-binding protein that plays a role in cell adh...
BACKGROUND: Galectin-3 staining of fine-needle aspiration (FNA) samples is very useful for diagnosis...
OBJECTIVE: To analyze the utility of galectin-3 (Gal3) immunohistochemistry (IHC) on preoperatively...
Abstract: Background. Thyroid nodules are the most com-mon surgical disease of the thyroid. Fine-nee...
The distinction between benign and malignant thyroid tumors is critical for the management of patien...
Thyroid cancer is not very common, accounting for 1-2% of all cancers, with a population incidence o...
Introduction: Most of differentiated thyroid carcinomas should be easily revealed by fine-needle as...
Background: Galectin-3 is an endogenous beta-galactoside binding lectin implicated in neoplastic tra...
BACKGROUND: In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed in 2007, ...
The histologic diagnosis of the follicular variant of papillary thyroid carcinoma (FVPTC) may be tro...
Abstract: Background. Galectin-3 has been recently recog-nized as a promising presurgical marker of ...
BACKGROUND: In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed in 2007,...
Thyroid cancer is not very common, accounting for 1-2% of all cancers, with a population incidence o...
Ten to fifteen percent of fine-needle aspiration biopsy (FNAB) of thyroid nodules are indeterminate....
Abstract: Background. The determination of malignancy in follicular patterned thyroid lesions is bas...
OBJECTIVE AND DESIGN: Galectin-3 is a beta-galactoside-binding protein that plays a role in cell adh...
BACKGROUND: Galectin-3 staining of fine-needle aspiration (FNA) samples is very useful for diagnosis...
OBJECTIVE: To analyze the utility of galectin-3 (Gal3) immunohistochemistry (IHC) on preoperatively...
Abstract: Background. Thyroid nodules are the most com-mon surgical disease of the thyroid. Fine-nee...
The distinction between benign and malignant thyroid tumors is critical for the management of patien...